Clinical Trials on Neurofibromatosis Type 1-Associated Plexiform Neurofibromas in United States
Total 306 results
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
National Cancer Institute (NCI)TerminatedNeurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord NeurofibromaUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 (NF1) | Plexiform Neurofibromas (PN)United States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharmaActive, not recruitingNeurofibromatosis Type 1 | Plexiform NeurofibromaUnited States
-
Children's National Research InstituteActive, not recruitingNeurofibromatosis 1 | Neurofibroma | Plexiform Neurofibroma | Atypical Neurofibroma | Atypical Neurofibromatosis | Von Recklinghausen DiseaseUnited States
-
AlexionRecruiting
-
Spectrum Health HospitalsVan Andel Research InstituteRecruitingNeurofibromatosis Type 1 | Plexiform Neurofibromas | Cutaneous NeurofibromasUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Plexiform NeurofibromasUnited States
-
Children's Hospital of PhiladelphiaCompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
Kent RobertsonCompletedNeurofibromatosis | NeurofibromasUnited States
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Poland, Russian Federation
-
Indiana UniversityNovartisCompletedNeurofibromatosis | NF1 | NeurofibromasUnited States
-
National Cancer Institute (NCI)RecruitingNeurofibromatosis 1 | Plexiform NeurofibromasUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States
-
Shanghai Fosun Pharmaceutical Industrial Development...Active, not recruitingNeurofibromatosis 1 | NF1 | Plexiform NeurofibromaUnited States, China, Spain
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibromas | NF1United States
-
Indiana UniversityPfizer; United States Department of DefenseTerminatedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZenecaCompletedNeurofibromatosis Type 1 | Optic Nerve Glioma | Plexiform NeurofibromaUnited Kingdom
-
National Cancer Institute (NCI)Completed
-
Indiana UniversityCompleted
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
UNC Lineberger Comprehensive Cancer CenterCompletedOptic Glioma | Plexiform Neurofibroma | Neurofibromatosis-1United States
-
National Cancer Institute (NCI)CompletedNeurofibroma, Plexiform | Neurofibromatosis Type IUnited States, Germany
-
Indiana UniversityWithdrawnNeurofibroma, PlexiformUnited States
-
University of PittsburghNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibroma | Neurofibromatosis Type 1 | Malignant Peripheral Nerve Sheath Tumor | Optic Glioma | Plexiform NeurofibromaUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis | MPNSTUnited States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
Massachusetts General HospitalJohns Hopkins UniversityActive, not recruitingCutaneous NeurofibromaUnited States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1United States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Peripheral Nerve Neoplasms, MalignantUnited States
-
National Cancer Institute (NCI)CompletedNeurofibroma | Neurofibromatosis Type 1United States
-
Children's Hospital of PhiladelphiaUnited States Department of DefenseTerminated
-
Donald BaselRecruiting
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Neurofibroma, PlexiformUnited States
-
National Cancer Institute (NCI)Completed
-
NFlection Therapeutics, Inc.CompletedNeurofibromatosis 1 | Cutaneous NeurofibromaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Neoplasm of Uncertain Malignant PotentialUnited States
-
Spectrum Health HospitalsCompleted
-
Harry T Whelan, MDCompletedNeurofibromatosesUnited States
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada